Frank Milton Schabel
#123,251
Most Influential Person Now
Frank Milton Schabel's AcademicInfluence.com Rankings
Frank Milton Schabelphilosophy Degrees
Philosophy
#5646
World Rank
#8511
Historical Rank
Logic
#2886
World Rank
#3957
Historical Rank

Frank Milton Schabelbiology Degrees
Biology
#7600
World Rank
#10549
Historical Rank
Biochemistry
#1050
World Rank
#1164
Historical Rank

Download Badge
Philosophy Biology
Frank Milton Schabel's Degrees
- PhD Biochemistry University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
Why Is Frank Milton Schabel Influential?
(Suggest an Edit or Addition)Frank Milton Schabel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA. (1964) (835)
- Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. (1975) (602)
- Experimental evaluation of potential anticancer agents VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia. (1963) (403)
- cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. (1979) (347)
- Concepts for systemic treatment of micrometastases (1975) (343)
- Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. (1984) (341)
- Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules. (1970) (320)
- Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. (1967) (298)
- Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas (1977) (204)
- The Antiviral Activity of 9-β-D-Arabinofuranosyladenine (ARA-A) (1968) (185)
- 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review. (1972) (163)
- The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors. (1969) (161)
- Patterns of resistance and therapeutic synergism among alkylating agents. (1978) (144)
- Quantitative evaluation of anticancer agent activity in experimental animals (1977) (135)
- Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase. (1980) (128)
- Antiviral Effect of Guanidine (1961) (120)
- Establishment of cross-resistance profiles for new agents. (1983) (111)
- Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy. (1978) (108)
- Biologic activity of 9-β-d-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-β-d-arabinofuranosyladenine (1977) (106)
- Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology (1984) (91)
- Rationale for adjuvant chemotherapy (1977) (89)
- Experimental evaluation of potential anticancer agents. VI. Anatomical distribution of leukemic cells and failure of chemotherapy. (1961) (87)
- Structure-activity relationships and cross-resistance observed on evaluation of a series of purine analogs against experimental neoplasms. (1959) (85)
- Inhibition of ribonucleotide reductase, DNA synthesis, and L1210 leukemia by guanazole. (1970) (84)
- THE MECHANISM OF ACTION OF 3‐DEAZAURIDINE IN TUMOR CELLS SENSITIVE AND RESISTANT TO ARABINOSYLCYTOSINE * (1975) (82)
- In vivo antiviral properties of biologically active compounds. II. Studies with influenza and vaccinia viruses. (1968) (81)
- EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIV. FURTHER STUDY OF CERTAIN BASIC CONCEPTS UNDERLYING CHEMOTHERAPY OF LEUKEMIA. (1965) (78)
- Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors. (1975) (75)
- Toxicity and anticancer activity of a new triazine antifolate (NSC 127755). (1982) (73)
- Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cells. (1978) (71)
- Surgical adjuvant chemotherapy of metastatic murine tumors (1977) (68)
- Structure-activity relationships observed on screening a series of pyrazolopyrimidines against experimental neoplasms. (1957) (63)
- Nitrosoureas: a review of experimental antitumor activity. (1976) (60)
- Concepts for controlling drug-resistant tumor cells. (1980) (58)
- Induced mammary carcinoma in the female rat as a drug evaluation system. (1966) (58)
- Experimental evaluation of potenital anticancer agents. XVII. Kinetics of growth and regression after treatment of certain solid tumors. (1965) (56)
- Experimental evaluation of potential anticancer agents. IX. The ribonucleosides and ribonucleotides of two purine antagonists. (1962) (56)
- Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology. (1984) (54)
- Comparative chemotherapy of AKR lymphoma and human hematological neoplasia. (1974) (53)
- Success and failure in the treatment of solid tumors. II. Kinetic parameters and "cell cure" of moderately advanced carcinoma 755. (1969) (53)
- Studies on the mode of action of azaserine. (1956) (51)
- Experimental evaluation of potential anticancer agents. XIX. Sensitivity of nondividing leukemic cell populations to certain classes of drugs in vivo. (1965) (51)
- On the curability of experimental neoplasms. I. Amethopterin and mouse leukemias. (1957) (49)
- Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents. (1982) (46)
- Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy. (1972) (45)
- Experimental evaluation of potential anticancer agents. XVI. Basic study of effects of certain anticancer agents on kinetic behavior of model bacterial cell populations. (1965) (45)
- On the carcinogenicity of a single intragastric dose of hydrocarbons, nitrosamines, aromatic amines, dyes, coumarins, and miscellaneous chemicals in female Sprague-Dawley rats. (1966) (44)
- Antiviral agents as adjuncts in cancer chemotherapy. (1980) (43)
- Success and failure in the treatment of solid tumors. I. Effects of cyclophosphamide (NSC-26271) on primary and metastatic plasmacytoma in the hamster. (1968) (43)
- Toxicity Studies in Mice Treated with 1-β-d-Arabinofuranosyl-cytosine (ara-C) (1969) (39)
- Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia. (1969) (37)
- Basic and therapeutic trial results obtained in the spontaneous AK leukemia (lymphoma) model-end of 1971. (1972) (35)
- Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters. (1968) (35)
- A comparative study of the anticancer activity of some S-substituted derivatives of 6-mercaptopurine and their ribonucleosides. (1961) (34)
- Spontaneous AK leukemia (lymphoma) as a model system. (1969) (33)
- Antiviral activity of carbobenzosy di- and tripeptides on measles virus. (1968) (32)
- Concepts for treatment of micrometastases developed in murine systems. (1976) (31)
- Experimental evaluation of potential anticancer agents. 28. Effects of therapy on viability and rate of proliferation of leukemic cells in various anatomic sites. (1965) (28)
- Evaluation of whole-body hyperthermia as an adjunct to chemotherapy in murine tumors. (1979) (28)
- Raised somatomedin associated with normal growth hormone. A cause of Beckwith-Wiedemann syndrome? (1980) (28)
- Altered sensitivity of a hamster plasmacytoma to cytosine arabinoside (NSC-63878). (1970) (28)
- Experimental Evaluation of Potential Anticancer Agents: XII. Quantitative Drug Response of the SA180, CA755, and Leukemia L1210 Systems to a “Standard List” of “Active” and “Inactive” Agents (1963) (27)
- Experimental evaluation of potential anticancer agents. I. Quantitative therapeutic evaluation of certain purine analogs. (1961) (26)
- Design and evaluation of combination chemotherapy trials in experimental animal tumor systems. (1979) (24)
- Some variables in experimental tumor systems which complicate interpretation of data from in vivo kinetic and pharmacologic studies with anticancer drugs. (1978) (23)
- Experimental evaluation of potential anticancer agents. XX. Development of immunity to leukemia L1210 in BDF mice and effects of therapy. (1966) (23)
- Studies on the mechanism of action and anticancer activity of N-methylformamide. (1955) (22)
- Drug control of Ara-C-resistant tumor cells. (1982) (22)
- Test Systems for Evaluating the Antitumor Activity of Nucleoside Analogues (1979) (22)
- Observations on Antiviral Activity of Netropsin.∗ (1953) (21)
- Screening for and biological characterization of antitumor agents using microorganisms. (1961) (21)
- Proliferative capacity of leukemic cells in AKR leukemia. (1970) (20)
- Inhibition of gross leukemia virus-induced plaque formation in XC cells by 3-deazauridine. (1974) (20)
- Therapeutic activity of mitoxantrone and ametantrone against murine tumors. (1983) (19)
- The "sensitivity" of resting and dividing cells. (1970) (18)
- A quick reference chart on cross resistance between anticancer patients. (1972) (18)
- NEW EXPERIMENTAL DRUG COMBINATIONS WITH POTENTIAL CLINICAL UTILITY (1975) (16)
- Combination chemotherapy for spontaneous AKR lymphoma. (1974) (16)
- In vitro effect of a variety of biologically active compounds on human cytomegalovirus. (1972) (15)
- Clonogenicity and growth of experimental tumors in relation to developing resistance and therapeutic failure. (1981) (15)
- Experimental evaluation of potential anticancer agents. IV. Host weight loss as it relates to false positives in drug evaluation. (1961) (15)
- Experimental evaluation of potential anticancer agents. VII. Cross resistance of alkylating agent-resistant neoplasms. (1962) (15)
- Chemotherapy of leukemia L1210 by 6-mercaptopurine (NSC-755) in combination with 6-methylthiopurine ribonucleoside (NSC-40774). (1967) (15)
- Response of five established solid transplantable mouse tumors and one mouse leukemia to hyperbaric hydrogen. (1978) (14)
- Growth requirements and biologic characteristics of leukemia L1210 cells in culture. (1966) (14)
- Experimental evaluation of potential anticancer agents XV. On the relative rates of growth and host kill of "single" leukemia cells that survive in vivo cytoxan therapy. (1966) (14)
- The inhibition of growth of sarcoma 180 by combinations of B6-antagonists and acid hydrazides. (1956) (14)
- Biologic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-beta-D-arabinofuranosyladenine. (1977) (13)
- Chapter 2 – COMBINATION CHEMOTHERAPY WITH NITROSOUREAS PLUS OTHER ANTICANCER DRUGS AGAINST ANIMAL TUMORS1 (1981) (13)
- IN VIVO ANTIVIRAL ACTIVITY OF 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA. (1965) (12)
- Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors. (1978) (12)
- Effect of 1,3-bis(2-chlorethyl)-1-nitrosourea (NSC-409962) and nitrogen mustard (NSC-762) on kinetic behavior of cultured L1210 leukemic cells. (1967) (12)
- Clinical concepts derived from animal chemotherapy studies. (1981) (11)
- Growth support of small B16 melanoma implants with nitrosourea-sterilized fractions of the same tumor. (1976) (11)
- Rationale for perioperative anticancer treatment. (1985) (11)
- Experimental evaluation of potential anticancer agents. II. Studies on the growth characteristics, metastases, and drug response of hamster neoplasms of diverse "sites of origin". (1961) (11)
- Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice (1980) (10)
- The antiviral activity of 9-beta-D-arabinofuranosyladenine (ARA-A). (1968) (10)
- Recovery of poliomyelitis virus from the throat during the incubation period. (1947) (10)
- Laboratory study of the epidemiology of poliomyelitis. (1948) (9)
- Reversal of the growth inhibitory action of urethan by 2, 6-diaminopurine. (1952) (9)
- Stool virus recovery in subclinical poliomyelitis during incubation, febrile, and convalescent periods. (1950) (9)
- Experimental evaluation of potential anticancer agents. V. In vitro cell culture as a tool in primary drug evaluation and antibiotic isolation. (1961) (9)
- Effects of a series of purine analogs on Friend leukemia virus infections in mice. (1968) (9)
- Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide. (1978) (8)
- Cell kinetics and the chemotherapy of murine solid tumors. (1980) (8)
- PURINE AND PYRIMIDINE NUCLEOSIDES AS ANTIVIRAL AGENTS—RECENT DEVELOPMENTS (1970) (8)
- [Clinical and immunological aspects of the Schoenlein-Henoch syndrome]. (1974) (8)
- Experimental evaluation of potential anticancer agents. X. A specificity test for distinguishing false positives. (1963) (8)
- Toxicity studies in mice treated with 1-beta-D-arabinofuranosylcytosine (ara-C). (1969) (7)
- Tumor stem cell heterogeneity: implications with respect to classification of cancers by chemotherapeutic effect. (1984) (7)
- Absence of delayed lethality in mice treated with aclacinomycin A (2004) (7)
- Hereditary deficiency of adenine phosphoribosyl transferase. (1980) (7)
- EXPERIENCES IN DEVELOPING POTENTIAL ANTIVIRAL COMPOUNDS (1965) (7)
- Structure-activity relationships and cross-resistance observed on evaluation of a series of purine analogs against experimental neoplasms. (1959) (7)
- Specific dna inhibitors vs leukemia l1210. Development of resistance to ara-c and ribonucleotide reductase inhibitors. Abstr. (1971) (6)
- Incidence of subclinical poliomyelitis in an urban area according to age groups. (1950) (6)
- Control of an acute Klebsiella pneumoniae infection in a rhesus monkey colony. (1968) (6)
- Inhibition of gross murine leukemia virus replication by rifamycin SV and certain of its derivatives in vitro. (1974) (6)
- UTILITY OF DRUG‐RESISTANT ORGANISMS IN CANCER CHEMOTHERAPY STUDIES (1958) (6)
- CISDIAMMINE DICHLOROPLATINUM II AOMBINATION CHEMOTHERAPY AND CROSS-RESISTANCE STUDIES WITH TUMORS OF MICE (1979) (6)
- Characterization of the biochemical basis of a complete deficiency of the adenine phosphoribosyl transferase (APRT) (2004) (5)
- Toxicity of several cancerigenic polycyclic hydrocarbons and other agents in AKR and C57BL-6 mice. (1967) (5)
- Potentiated Inhibition of Escherichia coli by Certain Combinations of Agents (1956) (5)
- Raised somatomedin associated with normal growth hormone (5)
- Susceptibility of the Hamster to St. Louis and Japanese Encephalitis Viruses by Feeding.∗ (1947) (4)
- Curative chemotherapy of advanced 239pu-induced osteosarcoma (239pu os) in mice with 2-beta-d-ribofuranosylthiazole-4- -carboxamide (t-car) and of advanced leukemia l1210 with t-car plus bcnu. Abstr. (1983) (4)
- Complete Adenine Phosphoribosyltransferase Deficiency with 2,8-Dihydroxyadenine Stone Formation (1981) (4)
- Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU. (1976) (4)
- [Studies on the occurrence of optic nerve diseases in the course of myambutol therapy]. (1972) (4)
- Isolation of Poliomyelitis Virus from Human Stools During the Incubation Period.∗ (1948) (4)
- Effects of a series of tumor-inhibiting agents and related compounds against a spectrum of mouse-adapted viruses. (1955) (3)
- Development of Friend leukemia virus in spleen and plasma of Swiss mice. (1965) (3)
- Experimental evaluation of potential anticancer agents. XI. Quantitative response of the Sa180 system to deoxypyridoxine. (1963) (3)
- In Vivo Antiviral Properties of Biologically Active Compounds (1968) (3)
- Synergistic antileukemic activity of combinations of two nitrosoureas. (1981) (3)
- Combination chemotherapy with cyclophosphamide plus melphalan against leukemia l1210. Abstr. (1975) (3)
- Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056). (1975) (3)
- The use of sulfadiazine and penicillin for treatment of experimental anthrax. (1946) (2)
- Shoes as a Potential Hazard to Surgical and Obstetrical Patients (1959) (2)
- Combination chemotherapy of ara-c-resistant leukemia p388 (p388/ara-c) with inhibitors of purine and pyrimidine biosynthesis. Abstr. (1983) (2)
- Studies on the antimicrobial nature of action of actinobolin. (1961) (2)
- Antiviral chemotherapy as an indicated adjunct to cancer chemotherapy. (1975) (2)
- Experimental evaluation of potential anticancer agents. III. Reproducibility of primary animal tumor systems employed in the C.C.N.S.C. program. (1961) (2)
- Therapeutic potentiation of antileukemic drugs. Abstr. (1968) (2)
- Observations on the susceptibility of sooty mangabeys (Cerococebus fuliginosus) and a baboon (Papio papio) to poliomyelitis. (1947) (2)
- VIRUS CHEMOTHERAPY - WHY AND HOW. (1965) (2)
- Historical development and future promise of the nitrosoureas as anticancer agents. (1973) (1)
- Metabolism and chemotherapeutic effects of 9-beta-d-arabino- furanosyl-2-fluoroadenine (f-araa) and evidence for its acti- vation by deoxycytidine kinase. Abstr. (1979) (1)
- Therapeutic synergism (ts) of ara-c plus methotrexate (mtx) against murine leukemia l1210. Abstr. (1981) (1)
- [Hydrothorax during the neonatal period (author's transl)]. (1979) (1)
- [Tetracyclin intoxication versus idiopathic pancreatitis: report of a case with multiple organ involvement (author's transl)]. (1979) (1)
- [Anaphylactoid purpura in infancy and childhood (author's transl)]. (1978) (1)
- [Glomerulonephritis following snake bite]. (1980) (1)
- Antibiotics as antitumor and antiviral substances; panel discussion. (1957) (1)
- Screening, the cornerstone of chemotherapy. (1972) (1)
- St. Louis and Japanese encephalitis in hamsters following natural feeding of the viruses. (1951) (1)
- [Apneas and periodic breathing in mature newborn infants]. (1987) (1)
- The "sensitivity" of resting and dividing cells. (1970) (1)
- Managers' career expectations are an individual matter (2012) (1)
- [Ocular findings in gout and hyperuricemia]. (1971) (1)
- [Medullary sponge kidney: a short review and a report of two cases (author's transl)]. (1976) (1)
- Spontaneous AK leukemia (lymphoma) as a model for human leukemias and lymphomas. (1972) (1)
- [Polycythemia in the newborn infant (author's transl)]. (1977) (0)
- Combination with cis-dichlorodiammineplatinum ii (cis)-ddpt or mitomycin c (mit c) against leukemia p388 (p388) in mice. Abstr. (1982) (0)
- [Infantile transitory distal renal tubular acidosis with bicarbonate loss]. (1985) (0)
- Host defense and maximal XYZ effect through small living isografts. (1959) (0)
- Inhibition of Ribonucleotide ReducÃ-ase , DNA Synthesis , and L 1210 Leukemia by Guana / (2006) (0)
- 5-fluorouracil (fu) Against leukemia p388 (p388/0) and ara-c- -resistant p388 (p388/ara-c). Abstr. (1982) (0)
- [Investigations on the pathogenesis of distal renal tubular acidosis (author's transl)]. (1979) (0)
- [Tubular secretion of phosphate in the human kidney (author's transl)]. (1978) (0)
- [Tubular and intestinal phosphate transport in vitamin D-resistant (hypophosphatemic) rickets (author's transl)]. (1977) (0)
- DISCUSSION (1965) (0)
- [Pharmacokinetic of antibiotics in patients with mucoviscidosis (author's transl)]. (1981) (0)
- [Renal glycosuria with loss of phosphate (author's transl)]. (1978) (0)
- Concepts for the treatment of tumor metastasis. (1983) (0)
- Some observations on the carcinostatic activity of Eponate on Fortner hamster plasmacytoma. (1963) (0)
- Laboratory studies on the epidemiology of poliomyelitis. (1947) (0)
- Arabinosyl Nucleosides and Nucleotides (2018) (0)
- [Pneumoperitoneum in a newborn without intestinal perforation (author's transl)]. (1979) (0)
- [Renal upper pole calyceal obstruction: clinical and radiological significance (author's transl)]. (1979) (0)
- Recovery of poliomyelitis virus from the throat during the incubation period. (1947) (0)
- William S. Wilcox 1922–1968 (1968) (0)
- Application of cancer chemotherapy: Introduction. (1978) (0)
- [Thrombosis of the renal artery in a newborn (author's transl)]. (1978) (0)
- Fundamentals in cancer chemotherapy: introduction. (1978) (0)
- Chemotherapy of experimental meningeal leukemia. Abstr. (1963) (0)
- Discourse on Kattenbach et al: Same Same but Different – Changing Career Expectations in Germany? (2012) (0)
- [Burkitt's lymphoma (author's transl)]. (1976) (0)
- [Exaggerated somatomedin activity in the Beckwith-Wiedemann syndrome (author's transl)]. (1979) (0)
- Susceptibility of Macacus cynomolgus to Japanese encephalitis virus with special reference to the alimentary tract. (1948) (0)
- The effect of treatment with a combination of 6-mercaptopurine and porfiromycin on an established Friend leukemia virus infection. (1969) (0)
- [Acid-base balance during exchange transfusion (author's transl)]. (1977) (0)
- ABSTRACT OF DISCUSSION (2017) (0)
- [Recurrent hemolytic-uremic syndrome with positive immunofluorescence]. (1985) (0)
- Isolation of the virus of poliomyelitis from the stools, oropharynx and nose of contacts. (1950) (0)
- Experimental evaluation of purine antagonists as anticancer agents. (1962) (0)
- [Aarskog syndrome (author's transl)]. (1981) (0)
- Fundamentals in cancer chemotherapy : anticancer symposia held in connection with the 10th International Congress of Chemotherapy, Zürich, September 18-23, 1977 (1978) (0)
- Departments in Transition: How Businesses Organise Their Knowledge Work (2012) (0)
- CAMPTOTHECIN OR A CAMPTOTHECIN DERVATIVE AND AN ALKYLATING AGENT FOR THE TREATMENT OF CANCER (2017) (0)
- Laboratory studies on the epidemiology of poliomyelitis. (1947) (0)
- Comparative antitumor activity of actinomycin analogs in mice bearing Ridgway osteogenic sarcoma or P388 leukemia. (1978) (0)
- [Study on seating furniture in pediatric institutions and a proposal for a new children's chair]. (1975) (0)
- EPIDEMIOLOGIC IMPLICATIONS OF POLIOMYELITIS VIRUS IN THE THROAT (1949) (0)
- Index rerum vol. 13 (1968) (0)
- [Polycystic disease of early infancy in two sisters (author's transl)]. (1979) (0)
- Title Page / Contents / Antibiotics and Chemotherapy, Vol. 23 Fundamentals in Cancer Chemotherapy (1978) (0)
- [Artificial ventilation of preterm and term infants (author's transl)]. (1978) (0)
- Recent Results in Cancer Research, Vol. 9. Immunological Aspects of Viral Oncolysis: Jean Lindenmann and Paul A. Klein. P. Rentchnick (ed.). New York: Springer-Verlag, Inc., 1967, 84 pp. $4.50 (1967) (0)
- [Experiences with the preventive use of aminophylline (Euphylline) in apnea and periodic respiration in infants]. (1988) (0)
- Effects of a Series of Furine Analogs on Friend Leukemia Virus Infections in Mice 1 (2006) (0)
- (p388/ara-c) To inhibitors of purine biosynthesis (ipub) and/or pyrimidine biosynthesis (ipyb). Abstr. (1983) (0)
- Contents, Vol. 13, 1968 (1968) (0)
- Mercury Intoxications During Application of Pharmaceutical Preparations (1980) (0)
- Index autorum vol. 13 (1968) (0)
- Adenosine deaminase inhibitor. Abstr. (1976) (0)
- A Simple Technic for Passage of Certain Viruses. (1947) (0)
- Some recent studies on viral encephalitides. (1951) (0)
- Complete regression of in vivo osteogenic sarcomas in mice with new azetomicins. Abstr. (1976) (0)
- -amino- 2-methyl-5-pyrimidinyl)methyl]-1-2:5,6-dianhydrogalactitol (dag) Against intracerebrally (ic) implanted leukemia l1210. Abstr. (1980) (0)
- GrowthSupportof Small B16 Melanoma Implantswith Nitrosourea-sterilizedFractionsof the Same Tumor1 (1976) (0)
- In Vivo Antiviral Activity of 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (1965) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Frank Milton Schabel?
Frank Milton Schabel is affiliated with the following schools: